| Active surveillance for clinically localized prostate cancer––A systematic review FB Thomsen, K Brasso, LH Klotz, MA Røder, KD Berg, P Iversen Journal of surgical oncology 109 (8), 830-835, 2014 | 248 | 2014 |
| Enzalutamide antitumour activity against metastatic castration-resistant prostate cancer previously treated with docetaxel and abiraterone: a multicentre analysis K Brasso, FB Thomsen, AJ Schrader, SC Schmid, D Lorente, M Retz, ... European urology 68 (2), 317-324, 2015 | 134 | 2015 |
| ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer KD Berg, B Vainer, FB Thomsen, MA Røder, TA Gerds, BG Toft, K Brasso, ... European urology 66 (5), 851-860, 2014 | 106 | 2014 |
| Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate FB Thomsen, MA Røder, P Rathenborg, K Brasso, M Borre, P Iversen Scandinavian journal of urology 48 (3), 268-275, 2014 | 73 | 2014 |
| Pulmonary function in patients with germ cell cancer treated with bleomycin, etoposide, and cisplatin J Lauritsen, MGG Kier, M Bandak, MS Mortensen, FB Thomsen, ... Journal Of Clinical Oncology 34 (13), 1492-1499, 2016 | 69 | 2016 |
| Active surveillance can reduce overtreatment in patients with low-risk prostate cancer FB Thomsen, MA Røder, H Hvarness, P Iversen, K Brasso Dan Med J 60 (2), A4575, 2013 | 64 | 2013 |
| Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study FB Thomsen, M Westerberg, H Garmo, D Robinson, L Holmberg, ... PLoS One 15 (1), e0228447, 2020 | 40 | 2020 |
| Improved survival for patients with de novo metastatic prostate cancer in the last 20 years KD Berg, FB Thomsen, MK Mikkelsen, IJ Ingimarsdóttir, RB Hansen, ... European Journal of Cancer 72, 20-27, 2017 | 39 | 2017 |
| The risk of biochemical recurrence for intermediate-risk prostate cancer after radical prostatectomy S Kurbegovic, KD Berg, FB Thomsen, L Gruschy, P Iversen, K Brasso, ... Scandinavian journal of urology 51 (6), 450-456, 2017 | 34 | 2017 |
| Active surveillance for localized prostate cancer: nationwide observational study FB Thomsen, H Jakobsen, NC Langkilde, M Borre, EB Jakobsen, A Frey, ... The Journal of urology 201 (3), 520-527, 2019 | 32 | 2019 |
| Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study FB Thomsen, K Brasso, IJ Christensen, JE Johansson, A Angelsen, ... European journal of cancer 51 (10), 1283-1292, 2015 | 31 | 2015 |
| Association of radical local treatment with mortality in men with very high-risk prostate cancer: a semiecologic, nationwide, population-based study P Stattin, F Sandin, FB Thomsen, H Garmo, D Robinson, IF Lissbrant, ... European Urology 72 (1), 125-134, 2017 | 30 | 2017 |
| A predictive model based on biparametric magnetic resonance imaging and clinical parameters for improved risk assessment and selection of biopsy-naïve men for prostate biopsies L Boesen, FB Thomsen, N Nørgaard, V Løgager, I Balslev, R Bisbjerg, ... Prostate Cancer and Prostatic Diseases 22 (4), 609-616, 2019 | 29 | 2019 |
| Gonadotropin-releasing hormone agonists, orchiectomy, and risk of cardiovascular disease: semi-ecologic, nationwide, population-based study FB Thomsen, F Sandin, H Garmo, IF Lissbrant, G Ahlgren, ... European urology 72 (6), 920-928, 2017 | 29 | 2017 |
| The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading–a matched‐pair analysis KD Berg, FB Thomsen, C Nerstrøm, MA Røder, P Iversen, BG Toft, ... BJU international 117 (6), 883-889, 2016 | 25 | 2016 |
| Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study FB Thomsen, K Brasso, KD Berg, TA Gerds, JE Johansson, A Angelsen, ... Annals of Oncology 27 (3), 460-466, 2016 | 24 | 2016 |
| Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older FB Thomsen, M Bandak, MF Thomsen, J Lauritsen, IJ Christensen, ... Cancer 120 (1), 43-51, 2014 | 23 | 2014 |
| Active surveillance for localized prostate cancer: an analysis of patient contacts and utilization of healthcare resources FB Thomsen, KD Berg, MA Røder, P Iversen, K Brasso Scandinavian Journal of Urology 49 (1), 43-50, 2015 | 18 | 2015 |
| Risk of malignant melanoma in men with prostate cancer: nationwide, population‐based cohort study FB Thomsen, Y Folkvaljon, H Garmo, D Robinson, S Loeb, C Ingvar, ... International Journal of Cancer 138 (9), 2154-2160, 2016 | 17 | 2016 |
| Prostate‐specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer FB Thomsen, IJ Christensen, K Brasso, MA Røder, P Iversen BJU international 113 (5b), E98-E105, 2014 | 17 | 2014 |
Klaus BrassoCopenhagen Prostate Cancer Center, Rigshospitalet.在 regionh.dk 的电子邮件经过验证
